annual cash & cash equivalents:
$188.23M+$80.66M(+74.98%)Summary
- As of today (August 2, 2025), AGL annual cash & cash equivalents is $188.23 million, with the most recent change of +$80.66 million (+74.98%) on December 31, 2024.
- During the last 3 years, AGL annual cash & cash equivalents has fallen by -$851.81 million (-81.90%).
- AGL annual cash & cash equivalents is now -81.90% below its all-time high of $1.04 billion, reached on December 31, 2021.
Performance
AGL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$136.94M-$51.29M(-27.25%)Summary
- As of today (August 2, 2025), AGL quarterly cash & cash equivalents is $136.94 million, with the most recent change of -$51.29 million (-27.25%) on March 31, 2025.
- Over the past year, AGL quarterly cash & cash equivalents has increased by +$25.23 million (+22.59%).
- AGL quarterly cash & cash equivalents is now -87.66% below its all-time high of $1.11 billion, reached on June 30, 2021.
Performance
AGL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AGL Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +75.0% | +22.6% |
| 3 y3 years | -81.9% | -86.6% |
| 5 y5 years | +52.3% | - |
AGL Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.9% | +75.0% | -79.5% | +27.3% |
| 5 y | 5-year | -81.9% | +76.3% | -87.7% | +30.1% |
| alltime | all time | -81.9% | +76.3% | -87.7% | +30.1% |
AGL Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $136.94M(-27.2%) |
| Dec 2024 | $188.23M(+75.0%) | $188.23M(+27.0%) |
| Sep 2024 | - | $148.16M(+35.3%) |
| Jun 2024 | - | $109.49M(-2.0%) |
| Mar 2024 | - | $111.71M(+3.8%) |
| Dec 2023 | $107.57M(-76.9%) | $107.57M(-36.1%) |
| Sep 2023 | - | $168.34M(-11.9%) |
| Jun 2023 | - | $190.98M(-51.6%) |
| Mar 2023 | - | $394.19M(-15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $465.30M(-55.3%) | $465.30M(-15.6%) |
| Sep 2022 | - | $551.29M(-17.5%) |
| Jun 2022 | - | $668.57M(-34.6%) |
| Mar 2022 | - | $1.02B(-1.8%) |
| Dec 2021 | $1.04B(+873.9%) | $1.04B(-3.8%) |
| Sep 2021 | - | $1.08B(-2.5%) |
| Jun 2021 | - | $1.11B(+953.6%) |
| Mar 2021 | - | $105.29M(-1.4%) |
| Dec 2020 | $106.80M(-13.6%) | $106.80M |
| Dec 2019 | $123.63M | - |
FAQ
- What is agilon health, inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for agilon health, inc.?
- What is agilon health, inc. annual cash & cash equivalents year-on-year change?
- What is agilon health, inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for agilon health, inc.?
- What is agilon health, inc. quarterly cash & cash equivalents year-on-year change?
What is agilon health, inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AGL is $188.23M
What is the all time high annual cash & cash equivalents for agilon health, inc.?
agilon health, inc. all-time high annual cash & cash equivalents is $1.04B
What is agilon health, inc. annual cash & cash equivalents year-on-year change?
Over the past year, AGL annual cash & cash equivalents has changed by +$80.66M (+74.98%)
What is agilon health, inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AGL is $136.94M
What is the all time high quarterly cash & cash equivalents for agilon health, inc.?
agilon health, inc. all-time high quarterly cash & cash equivalents is $1.11B
What is agilon health, inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AGL quarterly cash & cash equivalents has changed by +$25.23M (+22.59%)